RBC
CAH icon

Roble Belko & Company’s Cardinal Health CAH Stock Holding History

Roble Belko & Company’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Hold
96
– – ﹤0.01% 262
2026
Q1 		$20K Hold
96
– – ﹤0.01% 261
2025
Q4 		$20K Hold
96
– – ﹤0.01% 266
2025
Q3 		$15K Hold
96
– – ﹤0.01% 243
2025
Q2 		$16K Hold
96
– – ﹤0.01% 242
2025
Q1 		$13K Hold
96
– – ﹤0.01% 241
2024
Q4 		$11K Buy
+96
New +$11.2K ﹤0.01% 239
2019
Q4 		– Sell
-3,932
Closed -$186K – 334
2019
Q3 		$186K Hold
3,932
– – 0.05% 92
2019
Q2 		$185K Buy
+3,932
New +$181K 0.06% 90
2017
Q2 		– Sell
-60
Closed -$5K – 307
2017
Q1 		$5K Hold
60
– – ﹤0.01% 255
2016
Q4 		$4K Buy
+60
New +$4.34K ﹤0.01% 287

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Roble Belko & Company's CAH Position: Q2 2026 in Review

Roble Belko & Company held its Cardinal Health (CAH) position steady in Q2 2026 at 96 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Roble Belko & Company first reported a position in CAH in Q4 2016 and has held it in 11 quarters since. The position peaked at $186K in Q3 2019. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Roble Belko & Company held 96 shares of Cardinal Health worth $23K as of Q2 2026.
  • Roble Belko & Company left its Cardinal Health share count unchanged in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #262 holding.
  • Roble Belko & Company first reported a position in Cardinal Health in Q4 2016 and has held it in 11 quarters since.
  • Roble Belko & Company's Cardinal Health position peaked at $186K in Q3 2019.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.